Le Lézard
Classified in: Health, Covid-19 virus
Subject: SVY

Outlook on the Digital Respiratory Devices Global Market to 2030 - Focus on Sensors, Smart Inhalers & Nebulizers, Application, Countries and Competitive Landscape


DUBLIN, April 19, 2021 /PRNewswire/ -- The "Global Digital Respiratory Devices Market 2021-2030: Focus on Sensors, Smart Inhalers & Nebulizers, Application, 9 Countries' Data, and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The Global Digital Respiratory Devices Market is projected to reach $405.1 million by 2030. The study highlights that the market is set to witness a CAGR of 27.31% between 2021 and 2030.

This comprehensive study of the global digital respiratory devices market covers the following:

Besides these parameters, the study also encompasses the market growth drivers, opportunities, market restraining factors, competition mapping, end-user analysis, and COVID-19 impact on the market.

The study indicates that increasing prevalence of respiratory diseases, increasing adoption of digital technology among individuals, and treatment satisfaction with inhaled therapy among individuals are fueling the growth of the market.

The study highlights the various emerging opportunities, such as expansion into the emerging markets and predicting future exacerbations, which can be leveraged by players operating in the market.

Scope of the Report

The purpose of the study is to enable the reader to gain a holistic view of the Global Digital Respiratory Devices Market.

The report constitutes an in-depth analysis of the global digital respiratory devices market, including a thorough analysis of the different end-users. The study also provides exhaustive information on competitive landscape, brand share landscape, market share of the leading players, as well as other vital information with respect to the global digital respiratory devices market. The report considers sensors and apps, and smart inhalers and nebulizers.

Key Companies

Some of the key players contributing to the Global Digital Respiratory Devices Market include 3M Health Care Limited, Adherium Limited, Amiko Digital Health Limited, AstraZeneca, Boehringer Ingelheim International GmbH, Capsule Technologies, Cognita Labs, Cohero Health, Findair Sp. z. o. o, GlaxoSmithKline plc, Novartis AG, Pneuma Respiratory, Propeller Health, Sensiron AG, and Teva Pharmaceuticals Industries Ltd.

Key Questions Answered in this Report

How can market intelligence on digital respiratory device add value to an organization's decision-making process?

Key Topics Covered:

1 Market Overview
1.1 Introduction
1.2 Digital Respiratory Devices Market Ecosystem
1.3 Assumptions and Limitations

2 Market Dynamics
2.1 Impact Analysis
2.2 Market Drivers
2.2.1 Increasing Prevalence of Respiratory Diseases
2.2.2 Increasing Adoption of Digital Technology Among Individuals
2.2.3 Treatment Satisfaction with Inhaled Therapy Among Individuals
2.3 Market Restraints
2.3.1 Issues Related to The Accuracy and Reliability of the Device
2.3.2 Availability and High Cost Associated with Digital Respiratory Devices
2.4 Market Opportunities
2.4.1 Expansion into the Emerging Markets
2.4.2 Predicting Future Exacerbations

3 Analysis of COVID-19 Impact on Global Digital Respiratory Devices Market
3.1 Impact on Market Size
3.1.1 Scenario Comparative Analysis (Pre-COVID-19, During-COVID-19, Post-COVID-19)
3.1.2 Regional Impact
3.1.2.1 North America
3.1.2.2 Europe
3.1.2.3 Asia-Pacific
3.2 Impact on Digital Respiratory Devices Adoption
3.2.1 Short-Term Impact (2-4 Years)
3.2.2 Mid-Term Impact (5-8 Years)
3.2.3 Long-Term Impact (9-12 Years)
3.3 Entry Barrier and Opportunities for New Entrants

4 Competitive Landscape
4.1 Key Developments and Strategies
4.1.1 Agreements and Collaborations
4.1.2 Regulatory and Legal Activities
4.1.3 Investments, Funding, and Business Expansion
4.1.4 Mergers and Acquisitions
4.1.5 Awards and Recognitions
4.1.6 Product Launches
4.2 Market Share Analysis
4.3 Industry Attractiveness
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Power of Buyer
4.3.3 Threat of New Entrants
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry

5 Industry Insights
5.1 Opportunity Map Analysis of Smart Inhalers and Nebulizers
5.2 Smart Inhaler Value Propositions for Stakeholders
5.3 Smart Inhalers and Nebulizers - An Important Element of System for Predicting Disease Worsening in Individuals
5.4 Business Models for Digital Respiratory Devices Market

6 Global Digital Respiratory Devices Market (by Product Type)
6.1 Sensors and Apps
6.2 Smart Inhalers and Nebulizers

7 Global Digital Respiratory Devices Market (by Indication)
7.1 Asthma
7.2 Chronic Obstructive Pulmonary Disease (COPD)

8 Global Digital Respiratory Devices Market (by Region)
8.1 North America
8.1.1 U.S.
8.1.2 Canada
8.2 Europe
8.2.1 Germany
8.2.2 U.K.
8.2.3 France
8.2.4 Rest-of-Europe
8.3 Asia-Pacific (APAC)
8.3.1 Japan
8.3.2 China
8.3.3 Australia
8.3.4 India
8.3.5 Rest-of-Asia-Pacific (RoAPAC)
8.4 Rest-of-the-World (RoW)

9 Company Profiles
9.1 3M Health Care Limited
9.1.1 Company Overview
9.1.2 Role of 3M Health Care Limited in the Global Digital Respiratory Devices Market
9.1.3 Financials
9.1.3.1 Key Insights on the Financial Health of the Company
9.1.4 SWOT Analysis
9.2 Adherium Limited
9.2.1 Company Overview
9.2.2 Role of Adherium Limited in the Global Digital Respiratory Devices Market.
9.2.3 Financials
9.2.3.1 Key Insights on the Financial Health of the Company
9.2.4 SWOT Analysis
9.3 Amiko Digital Health Limited
9.3.1 Company Overview
9.3.2 Role of Amiko Digital Health Limited in the Global Digital Respiratory Devices Market
9.3.3 SWOT Analysis
9.4 AstraZeneca plc
9.4.1 Company Overview
9.4.2 Role of AstraZeneca plc in the Global Digital Respiratory Devices Market
9.4.3 Financials
9.4.3.1 Key Insights on the Financial Health of the Company
9.4.4 SWOT Analysis
9.5 Boehringer Ingelheim International GmbH
9.5.1 Company overview
9.5.2 Role of Boehringer Ingelheim International GmbH in the Global Digital Respiratory Devices Market
9.5.3 Financials
9.5.3.1 Key Insights on the Financial Health of the Company
9.5.4 SWOT Analysis
9.6 Capsule Technologies, Inc.
9.6.1 Company Overview
9.6.2 Role of Capsule Technologies, Inc. in the Global Digital Respiratory Devices Market.
9.6.3 SWOT Analysis
9.7 Cognita Labs
9.7.1 Company Overview
9.7.2 Role of Cognita Labs in the Global Digital Respiratory Devices Market
9.7.3 SWOT Analysis
9.8 Cohero Health
9.8.1 Company Overview
9.8.2 Role of Cohero Health in the Global Digital Respiratory Devices Market
9.8.3 SWOT Analysis
9.9 Findair Sp. z. o. o
9.9.1 Company Overview
9.9.2 Role of Findair Sp. z. o. o in the Global Digital Respiratory Devices Market
9.9.3 SWOT Analysis
9.1 GlaxoSmithKline plc
9.10.1 Company overview
9.10.2 Role of GlaxoSmithKline plc in the Global Digital Respiratory Devices Market
9.10.3 Financials
9.10.3.1 Key Insights on the Financial Health of the Company
9.10.4 SWOT Analysis
9.11 Novartis AG
9.11.1 Company overview
9.11.2 Role of Novartis AG in the Global Digital Respiratory Devices Market
9.11.3 Financials
9.11.3.1 Key Insights on the Financial Health of the Company
9.11.4 SWOT Analysis
9.12 Pneuma Respiratory, Inc.
9.12.1 Company Overview
9.12.2 Role of Pneuma Respiratory, Inc. in the Global Digital Respiratory Devices Market
9.12.3 SWOT Analysis
9.13 Propeller Health
9.13.1 Company Overview
9.13.2 Role of Propeller Health in the Global Digital Respiratory Devices Market
9.13.3 SWOT Analysis
9.14 Sensirion AG
9.14.1 Company overview
9.14.2 Role of Sensirion AG in the Global Digital Respiratory Devices Market
9.14.3 Financials
9.14.3.1 Key Insights on the Financial Health of the Company
9.14.4 SWOT Analysis
9.15 Teva Pharmaceuticals Industries Ltd.
9.15.1 Company Overview
9.15.2 Role of Teva Pharmaceuticals Industries Ltd. in the Global Digital Respiratory Devices Market
9.15.3 Financials
9.15.3.1 Key Insights on the Financial Health of the Company
9.15.4 SWOT Analysis

10 Research Scope and Methodology

For more information about this report visit https://www.researchandmarkets.com/r/neak2u

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 06:35
HEXO Corp ("HEXO" or the "Company") today announced Purchase and Sale Agreements in relation to its first US production facility, through a wholly owned US subsidiary. The ~50,000 sq. ft. facility, located in Northern Colorado, will provide US CPGs...

at 06:30
Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced today that the Sidney Kimmel Cancer Center ? Jefferson Health (SKCC) has joined Caris'...

at 06:30
The "Artificial Intelligence in Healthcare Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Component, Application, End User, and Geography" report has been added to ResearchAndMarkets.com's offering. Robot Assisted Surgery Segment...

at 06:10
Aurinia Pharmaceuticals Inc. (the "Company") today announced that members of the executive management team will participate in two upcoming investor conferences: RBC Capital Markets Global Healthcare Conference on Wednesday, May 19, 2021 at 10:55...

at 06:05
PharmaEssentia USA Corporation, a subsidiary of Taiwan-based PharmaEssentia Corp. (TPEx: 6446), a global biopharmaceutical innovator leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, today...

at 06:05
Metagenomi, a gene editing company, today presented preclinical data on three new CRISPR-associated gene editing systems useful for the development of novel cellular therapies, including T- and NK-cell therapies, at the 24th Annual Meeting of the...



News published on 19 april 2021 at 13:45 and distributed by: